We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > GeneCentric Therapeutics

News List

GeneCentric Therapeutics signs research alliance with Janssen pharmaceutical-technology
August 14, 2020
GeneCentric Therapeutics and Janssen Research & Development have formed a research alliance focused on RNA-based drug response biomarkers for non-muscle invasive bladder cancer (NMIBC).
GeneCentric Therapeutics Acquires Select ImmunoGenomics americanpharmaceuticalreview
August 20, 2019
GeneCentric Therapeutics has acquired Select ImmunoGenomics, a Chapel Hill, NC-based provider of advanced immunogenomic, data analysis and biomarker development services to support the development of immuno-oncology drugs.
GeneCentric Therapeutics Enters Bladder Cancer Research Collaboration with University of North Carolina pharmafocusasia
December 11, 2018
GeneCentric Therapeutics, Inc. today announced that it has entered into a research collaboration with the University of North Carolina at Chapel Hill (UNC) to assess patient response to....